The company is filing for Chapter 11 bankruptcy protection to focus on its transition into a telehealth services provider.

BMS pledges $40B over five years to boost U.S. R&D, tech innovation, and pharmaceutical manufacturing under CEO Christopher ...

Despite growing policy uncertainty, plenty of healthcare companies have managed to put up big returns, thanks to these ...